Trials / Completed
CompletedNCT00926224
Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Echosens · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of the study is to evaluate the diagnostic performance of the XL probe for estimating degree of liver fibrosis/cirrhosis in obese patients \> 28 kg/m² with various liver diseases in patients with chronic liver disease scheduled for a liver biopsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FibroScan M and XL probes | Each patient undergo two liver stiffness measurements with the FibroScan: once with the M probe and once with the XL probe |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-07-01
- Completion
- 2010-09-01
- First posted
- 2009-06-23
- Last updated
- 2010-11-16
Locations
5 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00926224. Inclusion in this directory is not an endorsement.